BR112017003644A2 - métodos de tratamento de distúrbios do sono e para regular produção de melatonina. - Google Patents
métodos de tratamento de distúrbios do sono e para regular produção de melatonina.Info
- Publication number
- BR112017003644A2 BR112017003644A2 BR112017003644A BR112017003644A BR112017003644A2 BR 112017003644 A2 BR112017003644 A2 BR 112017003644A2 BR 112017003644 A BR112017003644 A BR 112017003644A BR 112017003644 A BR112017003644 A BR 112017003644A BR 112017003644 A2 BR112017003644 A2 BR 112017003644A2
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- sleep disorders
- treating sleep
- melatonin production
- regulating melatonin
- Prior art date
Links
- 208000019116 sleep disease Diseases 0.000 title abstract 2
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 title 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 title 1
- 229960003987 melatonin Drugs 0.000 title 1
- 230000001105 regulatory effect Effects 0.000 title 1
- 201000001388 Smith-Magenis syndrome Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Electric Connection Of Electric Components To Printed Circuits (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
- Surface Acoustic Wave Elements And Circuit Networks Thereof (AREA)
- Processing Of Solid Wastes (AREA)
- Compositions Of Oxide Ceramics (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Coils Or Transformers For Communication (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Led Device Packages (AREA)
- Steroid Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462044856P | 2014-09-02 | 2014-09-02 | |
| US201562169635P | 2015-06-02 | 2015-06-02 | |
| PCT/US2015/047610 WO2016036619A1 (en) | 2014-09-02 | 2015-08-29 | Tasimelteon for treating smith-magenis syndrome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112017003644A2 true BR112017003644A2 (pt) | 2017-11-28 |
Family
ID=54147267
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112017003644A BR112017003644A2 (pt) | 2014-09-02 | 2015-08-29 | métodos de tratamento de distúrbios do sono e para regular produção de melatonina. |
Country Status (17)
| Country | Link |
|---|---|
| US (5) | US10179119B2 (enExample) |
| EP (2) | EP4137129A1 (enExample) |
| JP (3) | JP6903571B2 (enExample) |
| KR (2) | KR20240015729A (enExample) |
| CN (2) | CN116098887A (enExample) |
| AU (2) | AU2015312252B2 (enExample) |
| BR (1) | BR112017003644A2 (enExample) |
| CA (2) | CA3124872A1 (enExample) |
| DK (1) | DK3188727T3 (enExample) |
| ES (1) | ES2936833T3 (enExample) |
| FI (1) | FI3188727T3 (enExample) |
| HR (1) | HRP20230070T1 (enExample) |
| HU (1) | HUE061051T2 (enExample) |
| MX (1) | MX386150B (enExample) |
| PT (1) | PT3188727T (enExample) |
| SI (1) | SI3188727T1 (enExample) |
| WO (1) | WO2016036619A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2488392C2 (ru) * | 2006-05-22 | 2013-07-27 | Ванда Фармасьютиклз, Инк. | Лечение агонистом мелатонина |
| SI3188727T1 (sl) * | 2014-09-02 | 2023-03-31 | Vanda Pharmaceuticals Inc. | Tasimelteon za zdravljenje Smith-Magenisovega sindroma |
| BR112020017886A2 (pt) * | 2018-03-04 | 2021-03-23 | Vanda Pharmaceuticals Inc. | métodos para tratar um indivíduo experienciando um avanço na interrupção do ciclo de dormir-despertar na hora de dormir estabelecida do indivíduo, para tratar jet lag em um indivíduo e para reduzir uma consequência indesejada de um avanço de até oito horas em uma hora de dormir estabelecida do indivíduo, e, unidade de dispensação pré-empacotada |
| WO2020056117A1 (en) * | 2018-09-12 | 2020-03-19 | Vanda Pharmaceuticals Inc.. | Improving sleep or post-sleep performance |
| JP7503632B2 (ja) | 2019-12-13 | 2024-06-20 | バンダ・ファーマシューティカルズ・インコーポレイテッド | 液体タシメルテオン製剤及びそれを使用する方法 |
| JP7628127B2 (ja) | 2020-08-27 | 2025-02-07 | 株式会社ヨコオ | 検査装置 |
| AU2022345260A1 (en) * | 2021-09-14 | 2024-04-04 | Vanda Pharmaceuticals Inc. | Treatment of sleep disturbances in autism spectrum disorder patients |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA9711051B (en) | 1996-12-10 | 1999-06-09 | Bristol Myers Squibb Co | Benzodioxole benzofuran dihydrobenzofuran and benzodioxane melatonergic agents |
| US20050137247A1 (en) | 2003-12-22 | 2005-06-23 | The Brigham And Women's Hospital, Inc. | Methods and compositions for treatment of hypertension |
| US7754902B2 (en) | 2006-05-18 | 2010-07-13 | Vanda Pharmaceuticals, Inc. | Ruthenium(II) catalysts for use in stereoselective cyclopropanations |
| RU2488392C2 (ru) | 2006-05-22 | 2013-07-27 | Ванда Фармасьютиклз, Инк. | Лечение агонистом мелатонина |
| US20080260837A1 (en) | 2007-04-20 | 2008-10-23 | Qpharma, L.L.C. | Physically stable aqueous suspensions of active pharmaceuticals |
| KR100928515B1 (ko) | 2008-04-02 | 2009-11-26 | 주식회사 동부하이텍 | 데이터 수신 장치 |
| WO2011009102A1 (en) | 2009-07-16 | 2011-01-20 | Vanda Pharmaceuticals Inc. | Use of a melatonin agonist for the treatment of sleep disorders including primary insomnia |
| KR102171965B1 (ko) * | 2012-01-26 | 2020-10-30 | 반다 파마슈티칼즈, 인코퍼레이티드. | 일주기 리듬 장애의 치료 |
| CN102675268A (zh) * | 2012-05-18 | 2012-09-19 | 济南志合医药科技有限公司 | 制备（1r，2r）-2-（2,3-二氢苯并呋喃-4-基）环丙甲胺的方法 |
| US10376487B2 (en) * | 2013-11-12 | 2019-08-13 | Vanda Pharmaceuticals Inc. | Method of treatment |
| SI3188727T1 (sl) * | 2014-09-02 | 2023-03-31 | Vanda Pharmaceuticals Inc. | Tasimelteon za zdravljenje Smith-Magenisovega sindroma |
| JP7503632B2 (ja) * | 2019-12-13 | 2024-06-20 | バンダ・ファーマシューティカルズ・インコーポレイテッド | 液体タシメルテオン製剤及びそれを使用する方法 |
-
2015
- 2015-08-29 SI SI201531919T patent/SI3188727T1/sl unknown
- 2015-08-29 ES ES15766274T patent/ES2936833T3/es active Active
- 2015-08-29 FI FIEP15766274.3T patent/FI3188727T3/fi active
- 2015-08-29 HU HUE15766274A patent/HUE061051T2/hu unknown
- 2015-08-29 EP EP22199492.4A patent/EP4137129A1/en active Pending
- 2015-08-29 HR HRP20230070TT patent/HRP20230070T1/hr unknown
- 2015-08-29 JP JP2017512287A patent/JP6903571B2/ja active Active
- 2015-08-29 PT PT157662743T patent/PT3188727T/pt unknown
- 2015-08-29 CN CN202310255914.1A patent/CN116098887A/zh active Pending
- 2015-08-29 WO PCT/US2015/047610 patent/WO2016036619A1/en not_active Ceased
- 2015-08-29 CA CA3124872A patent/CA3124872A1/en active Pending
- 2015-08-29 DK DK15766274.3T patent/DK3188727T3/da active
- 2015-08-29 CN CN201580046852.7A patent/CN106604726A/zh active Pending
- 2015-08-29 US US15/326,934 patent/US10179119B2/en active Active
- 2015-08-29 CA CA2957588A patent/CA2957588C/en active Active
- 2015-08-29 MX MX2017002796A patent/MX386150B/es unknown
- 2015-08-29 KR KR1020247002426A patent/KR20240015729A/ko active Pending
- 2015-08-29 AU AU2015312252A patent/AU2015312252B2/en active Active
- 2015-08-29 EP EP15766274.3A patent/EP3188727B1/en active Active
- 2015-08-29 BR BR112017003644A patent/BR112017003644A2/pt not_active Application Discontinuation
- 2015-08-29 KR KR1020177009052A patent/KR20170048541A/ko not_active Ceased
-
2018
- 2018-12-06 US US16/211,687 patent/US10653665B2/en active Active
-
2020
- 2020-04-14 US US16/848,150 patent/US11266622B2/en active Active
- 2020-06-04 JP JP2020097599A patent/JP7132277B2/ja active Active
- 2020-09-22 AU AU2020239640A patent/AU2020239640B2/en active Active
-
2022
- 2022-01-14 US US17/648,046 patent/US20220133681A1/en not_active Abandoned
- 2022-03-14 JP JP2022039475A patent/JP7252390B2/ja active Active
-
2024
- 2024-05-08 US US18/658,100 patent/US20240293355A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112017003644A2 (pt) | métodos de tratamento de distúrbios do sono e para regular produção de melatonina. | |
| MX2024010175A (es) | Moleculas de anticuerpo contra april y usos de las mismas. | |
| BR112017006664A2 (pt) | terapias de combinação | |
| EA201692477A1 (ru) | Композиции и способы применения для лечения метаболических расстройств | |
| MX386598B (es) | Compuestos antibacterianos. | |
| NI201500117A (es) | Pirimidinas fusionadas sustituidas con trifluorometilo y sus usos. | |
| HK1220980A1 (zh) | 用於治疗庞贝氏症的方法和组合物 | |
| MX2017007148A (es) | Bacterias modificadas para tratar enfermedades asociadas con hiperamonemia. | |
| EA202090632A1 (ru) | Способы и композиции для лечения расстройств с использованием фоллистатиновых полипептидов | |
| MX2017001004A (es) | Dimensionamiento y posicionamiento adaptativos de ventanas de aplicacion. | |
| MX370506B (es) | Método para tratar trastorno de estrés post-traumático. | |
| MX2015011281A (es) | Composiciones de inh-c1 y metodos para la prevencion y el tratamiento de trastornos asociados con la deficiencia del inhibidor de c1 esterasa. | |
| BR112016025792A2 (pt) | meios e processos para tratamento de cmv | |
| CL2016000326A1 (es) | Composiciones y método para tratar condiciones asociadas con el complemento | |
| MX377593B (es) | Composiciones para usar en el tratamiento de cáncer renal. | |
| EA201600026A1 (ru) | Бактериальная гиалуронидаза и способ ее производства | |
| MX2017006019A (es) | Apilimod para uso en el tratamiento de melanoma. | |
| JO3541B1 (ar) | علاجات طبية قائمة على اناموريلين | |
| MX2016003002A (es) | Metodos para determinar la respuesta a la terapia. | |
| EP4487912A3 (en) | Improved treatment of atopic dermatitis with tradipitant | |
| TW201613628A (en) | Combination of valerian root extract and lavender oil for use in the treatment of sleep disorders | |
| MY181685A (en) | Methods and compositions comprising ursolic acid and/or resveratrol for treating obesity, diabetes, or cancer | |
| BR112016012248A2 (pt) | método de tratamento de nefropatia | |
| PH12016501658A1 (en) | Sialylated glycoprotein compositions and uses thereof | |
| MX2016010967A (es) | Nuevas composiciones para tratar lesiones neuronales mecanicas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B15N | Others concerning applications: notification of judicial decision |
Free format text: VARA: 25A VARA FEDERAL DO RIO DE JANEIROPROCESSO N.O 5022017-09.2019.4.02.5101) - NUP: 00408.027367/2019-14IMPETRANTE: KASZNAR LEONARDOS ADVOGADOSIMPETRADO: PRESIDENTE DO INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI?ANTE O EXPOSTO, DENEGO O MANDADO DE SEGURANCA E JULGO EXTINTO O PROCESSO SEM RESOLUCAO DO MERITO, COM FULCRO NO ARTIGO 6O, 5O, DA LEI NO 12.016/2009 C/C ARTIGO 485, VI DO CODIGO DE PROCESSO CIVIL.? |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |